Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab combined with chemoradiotherapy for recurrent or metastatic cervical cancer
ChiCTR2000029068Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2020
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of toripalimab in Cervical Cancer (CC), sponsored by First Affiliated Hospital of Soochow University. Started Jan 2020; status: recruiting.
02
Drugs
toripalimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2000029068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029068.